Eledoisin,
ELEDOISIN,
69-25-0,
Eledone peptide,
Eledoisin Acetate,
ELD 950,
ELD-950,
Eledoisin [INN],
Eledoisinum,
UNII-OKY3285J18,
CHEMBL373569,
Eledoisin (INN),
OKY3285J18,
Eledoisine [INN-French],
Eledoisina [INN-Spanish],
FI 6225 TF/Ocoa,
Eledoisina,
Eledoisine,
BRN 4796573,
5-Oxo-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-aspartyl-L-alanyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-L-methioninamide,
C54H85N13O15S,
DSSTox_CID_26926,
DSSTox_RID_82022,
DSSTox_GSID_46926,
SCHEMBL158143,
GTPL2086,
DTXSID1046926,
CHEBI:135903,
Tox21_112815,
BDBM50194558,
MFCD00076373,
AKOS024456851,
CAS-69-25-0,
NCGC00167276-01,
NTOC00000202-01,
O290,
FT-0654998,
C20029,
D07936,
069E250,
076E373,
Eledosin Acetate,
Eledoisin trifluoroacetate,
D0U9IB,
ACN-049486,
CID10328936,
C54-H85-N13-O15-S,
(3S)-3-[[(2S)-6-amino-2-[[(2S)-3-hydroxy-2-[[(2S)-1-[(2S)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid,